APi Group Corporation provides safety and specialty services worldwide. The company offers end-to-end integrated occupancy systems, such as fire protection services; heating, ventilation, and air conditioning solutions; and entry systems, elevators, and escalators, including design, installation, inspection, and service of these integrated systems. It also provides various infrastructure and specialized industrial plant services comprising maintenance and repair of underground electric, gas, water, sewer, and telecommunications infrastructure; engineering and design, fabrication, installation, maintenance service and repair, retrofitting and upgrading, pipeline infrastructure, access and road construction, supporting facilities, and integrity management and maintenance. The company serves commercial, education, healthcare, high tech, industrial, and special-hazard settings, as well as private and public utilities, communications, healthcare, education, transportation, manufacturing, industrial plants and governmental agencies. The company was formerly known as J2 Acquisition Limited and changed its name to APi Group Corporation in October 2019. APi Group Corporation was founded in 1926 and is headquartered in New Brighton, Minnesota.

APi Group Corporation

In a report released on April 2, Julian Harrison from BTIG reiterated a Buy rating on Apogee Therapeutics, with a price target of $137.00. The comp...

Apogee Therapeutics (APGE) Receives a Rating Update from a Top Analyst

CICC analyst maintained a Buy rating on Ascentage Pharma Group International yesterday and set a price target of HK$71.20. Ascentage Pharma Group I...

CICC Sticks to Their Buy Rating for Ascentage Pharma Group International (6855)

Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Apogee Therapeutics yesterday and set a price target of $160.00. The company’s share...

Guggenheim Keeps Their Buy Rating on Apogee Therapeutics (APGE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ascentage Pharma Group International Unsponsored ADR (AAPG), Rock...

Analysts Conflicted on These Healthcare Names: Ascentage Pharma Group International Unsponsored ADR (AAPG), Rocket Pharmaceuticals (RCKT) and Rhythm Pharmaceuticals (RYTM)

BTIG analyst Jeet Mukherjee reiterated a Buy rating on Ascentage Pharma Group International Unsponsored ADR yesterday and set a price target of $48...

BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Theriva Biologics (...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Apogee Therapeutics (APGE) and Theriva Biologics (TOVX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN), Apogee Therapeutics (APGE) and Gilead Sciences (GIL...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Apogee Therapeutics (APGE) and Gilead Sciences (GILD)

Traders seeking the top stock market stories for Monday will find them in the TipRanks daily wrap-up.


Morning News Wrap-Up 3/23/26: Today’s Biggest Stock Market Stories!

Apogee Therapeutics stock gained on Monday alongside strong results from the company’s latest clinical trial.


Why Did Apogee Therapeutics Stock (APGE) Soar Today?

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE...

Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)

An update from Apollo Gold ( ($TSE:APGO) ) is now available. Apollo Silver has appointed SLR Consulting to lead a Preliminary Economic Assessment f...

Apollo Silver Launches Economic Study and Exploration Push at Calico Project

An update from Ascentage Pharma Group International Unsponsored ADR ( ($AAPG) ) is now available. On March 13, 2026, Ascentage Pharma Group Interna...

Ascentage Pharma Sets March 25 Board Meeting on 2025 Results and Potential Final Dividend

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apogee Therapeutics (APGE – Research Report), Wave L...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	APG	$44.41	0.00%	2.42M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	APG	$44.41	0%	2.42M
3
4
5
6

APG

APG

Get APi Group Corporation Data in Excel

Get APi Group Corporation Data in Excel